THERAPEUTIC CLEARANCE OF COMPLEMENT FRAGMENT C5A

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1988
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
8033
Agency Tracking Number:
8033
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
1885 33rd St, Boulder, CO, 80301
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institute:
n/a
Abstract
THE OVERALL GOAL OF THE PROPOSED RESEARCH IS TO PROVIDE A SPECIFIC, PRACTICAL MEANS FOR INACTIVATING C5A IN PATIENTS AT RISK OF ADULT RESPIRATORY DISTRESS SYNDROME (ARDS). C5A IS A KEY CONTRIBUTORY, POSSIBLY NECESSARY FACTOR IN THE PATHOLOGICAL COURSE OF ARDS. THE PROTEINS CAPABLE OF INACTIVATING C5A NOTED IN THE LITERATURE ARE POORLY CHARACTERIZED. SYNERGEN'S SCIENTISTS HAVE SELECTED ONE OF THESE PROTEINS TO ISOLATE FROM HUMAN TISSUE, THEN CHARACTERIZE ITS MODE OF ACTION. AN ASSAY BASED ON THIS BIOLOGICAL ACTIVITY WILL BE USED TO PURIFY, CHARACTERIZE, CLONE AND EXPRESS THE PROTEIN BY RECOMBINANT DNA TECHNOLOGIES. BY REDUCING THE ACTION OF C5A IN PATIENTS AT RISK FOR ARDS, WE EXPECT THAT THE PROTEIN WILL PROVIDE A USEFUL THERAPEUTIC AGENT FOR PREVENTION OR AMELIORATION OF THE PATHOLOGY.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government